Novel insights into the circ_0003489/let-7b-5p/GLUT1 axis and its possible role in multiple myeloma

Xiaoyan Wang1, Qinqin Yang2, Yuedi Wu1

  • 1Department of Pharmacy, Zhongshan Hospital Xiamen University, Xiamen 361004, Fujian, China.

Transplant Immunology
|December 24, 2024
PubMed

Insights

Circular RNA hsa_circ_0003489 promotes multiple myeloma (MM) progression and bortezomib (BTZ) resistance by regulating the let-7b-5p microRNA and GLUT1 glucose transporter axis. Knockdown of circ_0003489 inhibits MM growth and reverses BTZ resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Circular RNAs (circRNAs) play crucial roles in the pathogenesis of multiple myeloma (MM).
  • The specific function of hsa_circ_0003489 (circ_0003489) in MM development and bortezomib (BTZ) resistance remains to be elucidated.

Purpose of the Study:

  • To investigate the role of circ_0003489 in multiple myeloma (MM) progression.
  • To determine the involvement of circ_0003489 in bortezomib (BTZ) resistance in MM.
  • To elucidate the molecular mechanism underlying circ_0003489's function in MM.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting for gene and protein expression analysis.
  • Cell proliferation, apoptosis, and glycolysis assays (EdU, CF, CCK-8, ECAR, glucose consumption, lactate production) to assess MM cell behavior.
  • Dual-luciferase reporter, RNA pull-down assays, and xenograft models to investigate molecular interactions and in vivo effects.

Main Results:

  • Circ_0003489 was significantly upregulated in MM patient samples and MM cell lines.
  • Silencing circ_0003489 inhibited MM cell proliferation, glycolysis, and bortezomib (BTZ) resistance, while promoting apoptosis.
  • Circ_0003489 acted as a sponge for let-7b-5p microRNA, negatively regulating its expression, and let-7b-5p microRNA targeted GLUT1 glucose transporter.

Conclusions:

  • Circ_0003489 promotes MM progression and bortezomib (BTZ) resistance.
  • The circ_0003489/let-7b-5p microRNA/GLUT1 axis is a key regulator of MM cell malignant behaviors and drug resistance.
  • Targeting circ_0003489 may represent a potential therapeutic strategy for overcoming bortezomib resistance in multiple myeloma.
Abstract